Back
Vivos Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
VVOS
Vivos Therapeutics, Inc.
Last Price:
$2.04
Seasonality Move:
-23.32%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VVOS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Vivos Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.01 | Buy |
| 20-day SMA: | 2.09 | Sell |
| 50-day SMA: | 2.37 | Sell |
| 200-day SMA: | 3.22 | Sell |
| 8-day EMA: | 1.58 | Buy |
| 20-day EMA: | 0.91 | Buy |
| 50-day EMA: | 0.43 | Buy |
| 200-day EMA: | 0.12 | Buy |
Vivos Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 42.25 | Sell |
| Chaikin Money Flow: | 31013 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.01 - 2.21) | Sell |
| Bollinger Bands (100): | (2.23 - 4.01) | Sell |
Vivos Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vivos Therapeutics, Inc. Stock
Is Vivos Therapeutics, Inc. Stock a Buy?
-
Vivos Therapeutics, Inc. share price is 2.06 while VVOS 8-day simple moving average is 2.01, which is a Buy signal.
-
The stock price of VVOS is 2.06 while Vivos Therapeutics, Inc. 20-day SMA is 2.09, which makes it a Sell.
-
Vivos Therapeutics, Inc. 50-day simple moving average is 2.37 while VVOS share price is 2.06, making it a Sell technically.
-
VVOS stock price is 2.06 and Vivos Therapeutics, Inc. 200-day simple moving average is 3.22, creating a Sell signal.
VVOS Technical Analysis vs Fundamental Analysis
Sell
43
Vivos Therapeutics, Inc. (VVOS)
is a Sell
Is Vivos Therapeutics, Inc. a Buy or a Sell?
-
Vivos Therapeutics, Inc. stock is rated a SellThe current Vivos Therapeutics, Inc. [VVOS] share price is $2.06. The Score for VVOS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Vivos Therapeutics, Inc. Stock Info
Market Cap:
18.5M
Price in USD:
2.06
Share Volume:
43.4K
Vivos Therapeutics, Inc. 52-Week Range
52-Week High:
7.95
52-Week Low:
1.93
Sell
43
Vivos Therapeutics, Inc. (VVOS)
is a Sell
Vivos Therapeutics, Inc. Share Price Forecast
-
What is the Vivos Therapeutics, Inc. stock price today?The Vivos Therapeutics, Inc. stock price is 2.06 USD today.
-
Will VVOS stock go up or go down?Vivos Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Vivos Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vivos Therapeutics, Inc. is overvalued.
Is Vivos Therapeutics, Inc. Stock a Buy?
-
Vivos Therapeutics, Inc. share price is 2.06 while VVOS 8-day exponential moving average is 1.58, which is a Buy signal.
-
The stock price of VVOS is 2.06 while Vivos Therapeutics, Inc. 20-day EMA is 0.91, which makes it a Buy.
-
Vivos Therapeutics, Inc. 50-day exponential moving average is 0.43 while VVOS share price is 2.06, making it a Buy technically.
-
VVOS stock price is 2.06 and Vivos Therapeutics, Inc. 200-day simple moving average is 0.12, creating a Buy signal.
Fundamental Analysis of Vivos Therapeutics, Inc.
Is Vivos Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and an increase next year of $0.91 per share.
Technical Analysis of Vivos Therapeutics, Inc.
Should I short Vivos Therapeutics, Inc. stock?
-
VVOS Moving Average Covergence Divergence (MACD) indicator is 0.53, suggesting Vivos Therapeutics, Inc. is a Buy
-
Vivos Therapeutics, Inc. Relative Strength Index (RSI) is 42.25, which suggest Vivos Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Vivos Therapeutics, Inc. is (2.01 - 2.21), which suggest Vivos Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Vivos Therapeutics, Inc. is (2.23 - 4.01), which suggest Vivos Therapeutics, Inc. is a Sell
* Vivos Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.